GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias Congratulations to Dr. Steven DeKosky on the publication of “GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias,” which appears in the April edition of JAMA Neurology. Abstract The association between glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) and risk of Alzheimer disease and related dementias (ADRD)…
https://neurology.ufl.edu/2025..../04/18/glp-1ra-and-s